CHGCF (Chugai Pharmaceutical Co) Other Current Liabilities: $811 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHGCF Chugai Pharmaceutical Co Ltd CHGCF
85 GF Score
Price $43.18
GF Value $49.32
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co Other Current Liabilities?

Chugai Pharmaceutical Co CHGCF -7.28% 85 Other Current Liabilities is $811 Mil as of Jun. 2026. GuruFocus rates CHGCF with a GF Score™ of 85/100 and a GF Value™ of $49.32 (Fairly Valued). The stock has 1 warning sign investors should review.

Chugai Pharmaceutical Co's other current liabilities for the quarter that ended in Jun. 2026 was $811 Mil.

Chugai Pharmaceutical Co's quarterly other current liabilities declined from Dec. 2025 ($1,237 Mil) to Mar. 2026 ($1,062 Mil) and declined from Mar. 2026 ($1,062 Mil) to Jun. 2026 ($811 Mil).

Chugai Pharmaceutical Co's annual other current liabilities declined from Dec. 2023 ($937 Mil) to Dec. 2024 ($756 Mil) but then increased from Dec. 2024 ($756 Mil) to Dec. 2025 ($1,237 Mil).

Chugai Pharmaceutical Co Other Current Liabilities Related Terms

Chugai Pharmaceutical Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Chugai Pharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co Other Current Liabilities Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 780.48 855.00 937.28 755.92 1,236.74

Chugai Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 817.13 981.73 1,236.74 1,061.89 810.72
CHGCF
85GF Score
Chugai Pharmaceutical Co Ltd CHGCF
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $811 Mil mean?
Chugai Pharmaceutical Co (CHGCF) has a Other Current Liabilities of $811 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Chugai Pharmaceutical Co.
Is Chugai Pharmaceutical Co's Other Current Liabilities too high?
Chugai Pharmaceutical Co's current Other Current Liabilities is $811 Mil. Overall, Chugai Pharmaceutical Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's Other Current Liabilities compare to LLY and JNJ?
Chugai Pharmaceutical Co's Other Current Liabilities of $811 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Chugai Pharmaceutical Co. Chugai Pharmaceutical Co's current Other Current Liabilities is $811 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co (CHGCF) is currently considered Fairly Valued. The stock's GF Value™ is $49.32, compared to a current price of $43.18 — trading 12.4% below its estimated fair value. The current Other Current Liabilities is $811 Mil. Chugai Pharmaceutical Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Chugai Pharmaceutical Co (CHGCF), the current Other Current Liabilities is $811 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (CHGCF) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of $43.18 is trading 12.4% below its estimated GF Value™ of $49.32. GuruFocus considers Chugai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for CHGCF:

  • Other Current Liabilities: $811 Mil
  • GF Value™: $49.32 vs. price of $43.18 (12.4% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the CHGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
85GF Score

Get the complete analysis for CHGCF

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.18
Price
$49.32
GF Value